See more : Hunan Hengguang Technology Co., Ltd. (301118.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Verano Holdings Corp. (VRNOF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Verano Holdings Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Solstad Offshore ASA (SLOFF) Income Statement Analysis – Financial Results
- Golden Matrix Group, Inc. (GMGI) Income Statement Analysis – Financial Results
- ValueInvest Global Akk KL (VAIGAKA.CO) Income Statement Analysis – Financial Results
- Star Paper Mills Limited (STARPAPER.BO) Income Statement Analysis – Financial Results
- AVZ Minerals Limited (AVZ.AX) Income Statement Analysis – Financial Results
Verano Holdings Corp. (VRNOF)
About Verano Holdings Corp.
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. It engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. The company offers artisanal cannabis products under the Encore, Avexia, MUV, and Verano brands for medical and adult-use markets. As of May 10, 2022, it operated 96 retail dispensaries, and 13 cultivation and processing facilities. The company is headquartered in Chicago, Illinois.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 938.45M | 879.41M | 737.85M | 290.79M | 85.66M |
Cost of Revenue | 463.25M | 456.35M | 403.29M | 118.29M | 38.86M |
Gross Profit | 475.21M | 423.06M | 334.56M | 172.50M | 46.80M |
Gross Profit Ratio | 50.64% | 48.11% | 45.34% | 59.32% | 54.63% |
Research & Development | 0.00 | 1.17M | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 179.54M | 233.83K | 57.96K |
Selling & Marketing | 0.00 | 0.00 | 8.64M | 0.00 | 1.20M |
SG&A | 331.93M | 356.57M | 188.18M | 233.83K | 57.96K |
Other Expenses | 58.49M | 116.15M | 41.78M | 0.00 | 0.00 |
Operating Expenses | 390.12M | 472.72M | 229.97M | 233.83K | 57.96K |
Cost & Expenses | 853.36M | 929.07M | 633.25M | 233.83K | 57.96K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 59.79M | 49.43M | 24.27M | 13.31M | 5.64K |
Depreciation & Amortization | 151.63M | 150.33M | 96.24M | 10.01M | 9.60M |
EBITDA | 239.22M | 36.35M | 169.50M | 97.76M | 5.58M |
EBITDA Ratio | 25.49% | 15.22% | 28.94% | -0.08% | -0.07% |
Operating Income | 84.78M | -16.46M | 107.68M | -233.83K | -57.96K |
Operating Income Ratio | 9.03% | -1.87% | 14.59% | -0.08% | -0.07% |
Total Other Income/Expenses | -56.99M | -2.27M | -19.88M | -9.85M | -5.64K |
Income Before Tax | 27.80M | -163.40M | 91.96M | -249.02K | -63.60K |
Income Before Tax Ratio | 2.96% | -18.58% | 12.46% | -0.09% | -0.07% |
Income Tax Expense | 145.15M | 105.47M | 104.13M | 15.19K | -3.26K |
Net Income | -117.35M | -268.87M | -12.17M | -264.22K | -60.34K |
Net Income Ratio | -12.50% | -30.57% | -1.65% | -0.09% | -0.07% |
EPS | -0.34 | -0.81 | -0.04 | 0.00 | 0.00 |
EPS Diluted | -0.34 | -0.81 | -0.04 | 0.00 | 0.00 |
Weighted Avg Shares Out | 344.07M | 331.41M | 287.54M | 290.00M | 290.00M |
Weighted Avg Shares Out (Dil) | 342.77M | 331.41M | 290.44M | 290.00M | 290.00M |
Verano Announces Upcoming Conference Participation
Marijuana Stocks To Watch Today In The Cannabis Sector
2 Marijuana Stocks For Your September Watchlist
2 Marijuana Stocks To Buy If For New Cannabis Investors
Verano Is Now My Favorite Large MSO (Rating Upgrade)
Verano Expands U.S. Cannabis Footprint With New Buyouts
3 Marijuana Stocks For Investors This Month
Top US Cannabis Stocks for September: Emerging Leaders to Watch
Verano Announces Closing of Acquisition of Arizona and Virginia Subsidiaries of The Cannabist Company, Becomes Exclusive Cannabis Operator for HSA 5 in Eastern Virginia and Strengthens Arizona Footprint
Verano, Green Thumb & MariMed's Strong Q2: Unpacking The Cannabis Earnings Surge
Source: https://incomestatements.info
Category: Stock Reports